SG11201501976SA - Methods for modulating corticosterone levels in psychologically stressed individuals - Google Patents
Methods for modulating corticosterone levels in psychologically stressed individualsInfo
- Publication number
- SG11201501976SA SG11201501976SA SG11201501976SA SG11201501976SA SG11201501976SA SG 11201501976S A SG11201501976S A SG 11201501976SA SG 11201501976S A SG11201501976S A SG 11201501976SA SG 11201501976S A SG11201501976S A SG 11201501976SA SG 11201501976S A SG11201501976S A SG 11201501976SA
- Authority
- SG
- Singapore
- Prior art keywords
- modulating
- methods
- corticosterone levels
- stressed individuals
- psychologically stressed
- Prior art date
Links
- OMFXVFTZEKFJBZ-UHFFFAOYSA-N Corticosterone Natural products O=C1CCC2(C)C3C(O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 OMFXVFTZEKFJBZ-UHFFFAOYSA-N 0.000 title 1
- OMFXVFTZEKFJBZ-HJTSIMOOSA-N corticosterone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OMFXVFTZEKFJBZ-HJTSIMOOSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Pediatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP12382354.4A EP2708145B1 (fr) | 2012-09-14 | 2012-09-14 | Compositions nutritionnelles pour utilisation dans des méthodes pour moduler les niveaux de corticostérone chez des individus psychologiquement stressés |
PCT/US2013/059436 WO2014043330A1 (fr) | 2012-09-14 | 2013-09-12 | Procédés permettant de moduler les niveaux de corticostérone chez des individus souffrant de stress psychologique |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201501976SA true SG11201501976SA (en) | 2015-04-29 |
Family
ID=46940436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201501976SA SG11201501976SA (en) | 2012-09-14 | 2013-09-12 | Methods for modulating corticosterone levels in psychologically stressed individuals |
Country Status (14)
Country | Link |
---|---|
US (3) | US10398716B2 (fr) |
EP (1) | EP2708145B1 (fr) |
CN (1) | CN104780781B (fr) |
BR (1) | BR112015005758A2 (fr) |
CA (1) | CA2884487C (fr) |
DK (1) | DK2708145T3 (fr) |
ES (1) | ES2572831T3 (fr) |
HK (1) | HK1195856A1 (fr) |
IL (1) | IL237589A0 (fr) |
MX (1) | MX369453B (fr) |
MY (1) | MY182944A (fr) |
PH (1) | PH12015500545A1 (fr) |
SG (1) | SG11201501976SA (fr) |
WO (1) | WO2014043330A1 (fr) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2708147B1 (fr) | 2012-09-14 | 2020-03-11 | Abbott Laboratories | Procédés pour augmenter la fonctionnalité du cerveau utilisant du 2-fucosyllactose |
ES2572831T3 (es) * | 2012-09-14 | 2016-06-02 | Abbott Laboratories | Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico |
TW201438719A (zh) | 2012-12-18 | 2014-10-16 | Abbott Lab | 改善壓力症狀之母乳寡糖 |
ES2708771T3 (es) * | 2012-12-20 | 2019-04-11 | Abbott Lab | Formulaciones nutricionales que usan oligosacáridos de leche humana para modular la inflamación |
US10987368B2 (en) | 2014-12-08 | 2021-04-27 | Glycom A/S | Synthetic composition for preventing or treating CVD |
CN115350200A (zh) | 2014-12-08 | 2022-11-18 | 格礼卡姆股份公司 | 用于治疗代谢障碍的合成组合物 |
US10835544B2 (en) | 2014-12-08 | 2020-11-17 | Glycom A/S | Synthetic composition for regulating satiety |
US20160287637A1 (en) * | 2014-12-08 | 2016-10-06 | Glycom A/S | Synthetic composition and method for modulating emotion and mood disorders |
US10881674B2 (en) | 2014-12-08 | 2021-01-05 | Glycom A/S | Synthetic composition for treating metabolic disorders |
EP3368047B1 (fr) | 2015-10-28 | 2023-04-26 | Glycom A/S | Composition synthétique et procédé de modulation des troubles émotionnels et de l'humeur |
US10835545B2 (en) | 2015-10-28 | 2020-11-17 | Glycom A/S | Synthetic composition and method for modulating brain function and behaviour |
WO2017215722A1 (fr) * | 2016-06-15 | 2017-12-21 | Glycom A/S | Composition de synthèse comprenant hmo et procédé de modulation des troubles de l'émotion et de l'humeur |
WO2018157900A1 (fr) * | 2017-03-01 | 2018-09-07 | Glycom A/S | Composition synthétique pour la modulation du microbiote |
US20180333426A1 (en) * | 2017-05-17 | 2018-11-22 | Mead Johnson Nutrition Company | Nutritional composition with human milk oligosaccharides and uses thereof |
MX2020012783A (es) * | 2018-06-25 | 2021-01-20 | Nestle Sa | Composicion que comprende oligosacaridos de la leche humana para uso en la mejora, refuerzo, promocion o modulacion de una funcion serotonergica en el sistema nervioso central. |
WO2024052406A1 (fr) * | 2022-09-06 | 2024-03-14 | Inbiose N.V. | Compositions nutritionnelles cuites comprenant des oligosaccharides de lait humain |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU694181B2 (en) * | 1994-03-09 | 1998-07-16 | Abbott Laboratories | Humanized milk |
US5891689A (en) | 1994-04-12 | 1999-04-06 | Innovir Laboratories, Inc. | Heme-bearing microparticles for targeted delivery of drugs |
KR970706271A (ko) | 1994-09-20 | 1997-11-03 | 스티븐슨 린다 에스. | 시냅스 전달 향상용 약제(drugs to improve synaptic transmission) |
RU2199317C2 (ru) | 1997-02-21 | 2003-02-27 | Абботт Лаборэтриз | Способ снижения заболеваемости некротическим энтероколитом у детей (варианты) |
US6365218B1 (en) | 2000-02-04 | 2002-04-02 | Abbott Laboratories | Pediatric formula and methods for providing nutrition and improving tolerance |
US6811801B2 (en) | 2001-12-12 | 2004-11-02 | Abbott Laboratories | Methods and compositions for brightening the color of thermally processed nutritionals |
US20110104716A1 (en) | 2003-08-08 | 2011-05-05 | Hasan Mohejeri | Novel method for screening brain-active compounds |
WO2008011538A2 (fr) | 2006-07-19 | 2008-01-24 | The Salk Institute For Biological Studies | Méthodes d'utilisation de flavonoïdes pour améliorer la mémoire |
EP2072052A1 (fr) * | 2007-12-17 | 2009-06-24 | Nestec S.A. | Prévention d'infections opportunistes dans des sujets dont l'immunité est fragilisée |
MX2011004142A (es) * | 2008-11-03 | 2011-05-25 | Nestec Sa | Una composicion nutricional que comprende probioticos y que mejora los patrones de sueño. |
CN102459295A (zh) | 2009-04-07 | 2012-05-16 | 格礼卡姆股份公司 | 2’-o-岩藻糖基乳糖的合成 |
EP2451462B1 (fr) * | 2009-07-06 | 2017-09-06 | Children's Hospital Medical Center | Inhibition de l'inflammation par des oligosaccharides du lait |
RU2530641C2 (ru) | 2009-07-15 | 2014-10-10 | Н.В. Нютрисиа | Фукозиллактоза в качестве неусвояемого олигосахарида, идентичного грудному молоку, с новой функциональной пользой |
EP3338784B1 (fr) | 2010-12-31 | 2020-07-22 | Abbott Laboratories | Oligosaccharides du lait humain pour la modulation de l'inflammation |
CA2822660C (fr) | 2010-12-31 | 2021-09-07 | Abbott Laboratories | Combinaison symbiotique de probiotique et d'oligosaccharides de lait humain |
MX352040B (es) * | 2010-12-31 | 2017-11-07 | Abbott Lab | Formulaciones nutricionales que incluyen los oligosacaridos de leche humana y los acidos grasos poliinsaturados de cadena larga y usos de las mismas. |
WO2012092156A1 (fr) | 2010-12-31 | 2012-07-05 | Abbott Laboratories | Méthodes visant à diminuer la fréquence de l'entérocolite nécrosante chez les nourrissons, les jeunes enfants ou les enfants à l'aide d'oligosaccharides du lait humain |
CN103379908B (zh) * | 2010-12-31 | 2020-02-14 | 雅培制药有限公司 | 使用人乳寡糖、维生素c和抗炎剂减少氧化应激的发病率的方法 |
EP3335576A1 (fr) | 2010-12-31 | 2018-06-20 | Abbott Laboratories | Oligosaccharides de lait humain pour favoriser la croissance de bactéries bénéfiques |
CN104126749A (zh) | 2011-02-10 | 2014-11-05 | 雀巢产品技术援助有限公司 | 使用人乳中发现的特定量的寡糖的组合调节双歧杆菌属的生长 |
ES2601891T3 (es) | 2011-10-18 | 2017-02-16 | Nestec S.A. | Composición para su uso en crecimiento cerebral y/o desarrollo cognitivo y/o psicomotor |
ES2572831T3 (es) | 2012-09-14 | 2016-06-02 | Abbott Laboratories | Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico |
EP2708147B1 (fr) | 2012-09-14 | 2020-03-11 | Abbott Laboratories | Procédés pour augmenter la fonctionnalité du cerveau utilisant du 2-fucosyllactose |
-
2012
- 2012-09-14 ES ES12382354.4T patent/ES2572831T3/es active Active
- 2012-09-14 DK DK12382354.4T patent/DK2708145T3/en active
- 2012-09-14 EP EP12382354.4A patent/EP2708145B1/fr active Active
-
2013
- 2013-09-12 MX MX2015003368A patent/MX369453B/es active IP Right Grant
- 2013-09-12 SG SG11201501976SA patent/SG11201501976SA/en unknown
- 2013-09-12 CN CN201380059247.4A patent/CN104780781B/zh active Active
- 2013-09-12 CA CA2884487A patent/CA2884487C/fr active Active
- 2013-09-12 WO PCT/US2013/059436 patent/WO2014043330A1/fr active Application Filing
- 2013-09-12 MY MYPI2015000645A patent/MY182944A/en unknown
- 2013-09-12 US US14/428,260 patent/US10398716B2/en active Active
- 2013-09-12 BR BR112015005758A patent/BR112015005758A2/pt not_active IP Right Cessation
-
2014
- 2014-09-16 HK HK14109322.4A patent/HK1195856A1/zh unknown
-
2015
- 2015-03-05 IL IL237589A patent/IL237589A0/en unknown
- 2015-03-13 PH PH12015500545A patent/PH12015500545A1/en unknown
-
2019
- 2019-08-30 US US16/557,461 patent/US11116779B2/en active Active
-
2021
- 2021-09-13 US US17/473,298 patent/US20210401862A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20210401862A1 (en) | 2021-12-30 |
US20150238508A1 (en) | 2015-08-27 |
WO2014043330A1 (fr) | 2014-03-20 |
US11116779B2 (en) | 2021-09-14 |
CA2884487C (fr) | 2017-08-29 |
MX2015003368A (es) | 2015-10-22 |
IL237589A0 (en) | 2015-04-30 |
CA2884487A1 (fr) | 2014-03-20 |
CN104780781B (zh) | 2017-03-01 |
HK1195856A1 (zh) | 2014-11-28 |
ES2572831T3 (es) | 2016-06-02 |
BR112015005758A2 (pt) | 2017-07-04 |
US20190381077A1 (en) | 2019-12-19 |
EP2708145A8 (fr) | 2014-09-03 |
CN104780781A (zh) | 2015-07-15 |
PH12015500545A1 (en) | 2015-05-04 |
DK2708145T3 (en) | 2016-07-18 |
EP2708145B1 (fr) | 2016-05-04 |
MY182944A (en) | 2021-02-05 |
EP2708145A1 (fr) | 2014-03-19 |
MX369453B (es) | 2019-11-08 |
US10398716B2 (en) | 2019-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL237589A0 (en) | Methods of regulating corticosterone levels in individuals with psychological stress | |
HK1205921A1 (en) | Excreta-handling device and method therefor | |
EP2903334A4 (fr) | Procédé et dispositif de transmission d'informations | |
EP2908780A4 (fr) | Dispositifs et méthodes d'alignement | |
EP2892026A4 (fr) | Dispositif d'authentification et procédé d'authentification | |
EP2930987A4 (fr) | Procédé et dispositif de transmission d'informations | |
EP2901151A4 (fr) | Dispositifs et procédés de diagnostic | |
EP2663864B8 (fr) | Procédé d'évaluation de la biodiversité et son utilisation | |
HK1201695A1 (en) | Noodle-steaming method and noodle-steaming device | |
HK1205905A1 (en) | Deglutition simulation device and method | |
EP2892276A4 (fr) | Procédé et dispositif de répartition de données | |
EP2876588A4 (fr) | Dispositif de gestion de flux de travaux et procédé de gestion de flux de travaux | |
EP2806084A4 (fr) | Dispositif de formage et procédé de construction utilisant le dispositif de formage | |
HK1207461A1 (en) | Graph-drawing device and graph-drawing method | |
EP2931140A4 (fr) | Dispositifs et procédés de réparation de tissus | |
EP2806020A4 (fr) | Dispositif de sélection de sujet et procédé de sélection de sujet | |
EP2869533A4 (fr) | Procédé et dispositif de distribution de données | |
EP2928085A4 (fr) | Dispositif d'utilisateur et procédé associé | |
HK1221778A1 (zh) | 曝光裝置及曝光方法 | |
EP2804539A4 (fr) | Dispositif et procédé d'acquisition de tissu | |
EP2835742A4 (fr) | Dispositif et procédé de gestion | |
EP2940457A4 (fr) | Dispositif de tomographie assistée par ordinateur (ct) et procédé associé | |
EP2889895A4 (fr) | Dispositif d'empreinte et procédé d'empreinte | |
EP2815868A4 (fr) | Dispositif d'impression et procédé d'impression | |
GB201222362D0 (en) | Device and method |